Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2012 1
2013 1
2014 3
2015 4
2016 2
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.
Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, Wu W, Niu N, Sukhanova M, Pei J, Baldwin DA, Nejati R, Wasik MA, Khan N, Tu Y, Gao J, Chen Y, Ma S, Larson RA, Wang YL. Lu P, et al. Among authors: franzen ca. Blood Cancer J. 2021 Feb 18;11(2):39. doi: 10.1038/s41408-021-00429-z. Blood Cancer J. 2021. PMID: 33602908 Free PMC article.
13 results